Evidence map›Paper›PMID 30948248›Full record

ArticleMolecular metabolism2019

Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism.

Gisela Geoghegan, Judith Simcox, Marcus M Seldin, Timothy J Parnell, Chris Stubben, Steven Just, Lori Begaye, Aldons J Lusis, Claudio J Villanueva

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  11. Article
  12. Article
  13. NADH dehydrogenase reverses dietary and clock metabolic syndrome.bioRxiv : the preprint server for biology · 2025
    Article
  14. Reduced Growth and Inflammation in Lrp5Journal of cellular and molecular medicine · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Gisela GeogheganDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA.
Judith SimcoxDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA.
Marcus M SeldinDepartment of Human Genetics/Medicine, University of California, Los Angeles, CA, USA; Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA, USA.
Timothy J ParnellBioinformatics Shared Resources, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Chris StubbenBioinformatics Shared Resources, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Steven JustDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA.
Lori BegayeDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA.
Aldons J LusisDepartment of Human Genetics/Medicine, University of California, Los Angeles, CA, USA; Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA, USA.
Claudio J VillanuevaDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA. Electronic address: villanueva@biochem.utah.edu.
University of Utah · USUniversity of California, Los Angeles · US

Funding

WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI James Alexander Fitzpatrick · 2013 to 2026
$27.1M
RESEARCH TRAINING IN HEMATOLOGYT32DK007115 · NIDDK · UNIVERSITY OF UTAH · PI LEIBOLD, ELIZABETH ANN, PRCHAL, JOSEF T · 1986 to 2020
$8.4M
Interdisciplinary Training Program in MetabolismT32DK091317 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI SCOTT A SUMMERS · 2011 to 2026
$4.8M
Role of TLE3 in the transcriptional regulation of beige adipocytesR01DK103930 · NIDDK · UNIVERSITY OF UTAH · PI VILLANUEVA, CLAUDIO J · 2015 to 2019
$1.7M
Transcriptional role of TLE3 in brown adipose tissue development and metabolismK01DK097285 · NIDDK · UNIVERSITY OF UTAH · PI VILLANUEVA, CLAUDIO J · 2013 to 2015
$480k
Transcriptional regulation of beige adipocytesR03DK103089 · NIDDK · UNIVERSITY OF UTAH · PI VILLANUEVA, CLAUDIO J · 2014 to 2015
$149k
NIDDK NIH HHS K01 DK097285NIDDK NIH HHS P30 DK020579NIDDK NIH HHS R01 DK103930NIDDK NIH HHS R03 DK103089NIDDK NIH HHS T32 DK007115NIDDK NIH HHS T32 DK091317
6 · The paper itself

Abstract

objectiveActivation of the Wnt-signaling pathway is known to inhibit differentiation in adipocytes. However, there is a gap in our understanding of the transcriptional network regulated by components of the Wnt-signaling pathway during adipogenesis and in adipocytes during postnatal life. The key intracellular effectors of the Wnt-signaling pathway occur through TCF transcription factors such as TCF7L2 (transcription factor-7-like 2). Several genetic variants in proximity to TCF7L2 have been linked to type 2 diabetes through genome-wide association studies in various human populations. Our work aims to functionally characterize the adipocyte specific gene program regulated by TCF7L2 and understand how this program regulates metabolism.

methodsWe generated Tcf7l2

resultsHere we report that TCF7L2 regulates adipocyte size, endocrine function, and glucose metabolism. Tcf7l2 is highly expressed in white adipose tissue, and its expression is suppressed in genetic and diet-induced models of obesity. Genome-wide distribution of TCF7L2 binding and gene expression analysis in adipocytes suggests that TCF7L2 directly regulates genes implicated in cellular metabolism and cell cycle control. When challenged with a high-fat diet, conditional deletion of TCF7L2 in adipocytes led to impaired glucose tolerance, impaired insulin sensitivity, promoted weight gain, and increased adipose tissue mass. This was accompanied by reduced expression of triglyceride hydrolase, reduced fasting-induced free fatty acid release, and adipocyte hypertrophy in subcutaneous adipose tissue.

conclusionsTogether our studies support that TCF7L2 is a central transcriptional regulator of the adipocyte metabolic program by directly regulating the expression of genes involved in lipid and glucose metabolism.

Indexed as

AdipocytesAnimalsCells, CulturedGlucoseLipid MetabolismMaleMiceMice, Inbred C57BLTranscription Factor 7-Like 2 ProteinWeight GainGlucoseTcf7l2 protein, mouseTranscription Factor 7-Like 2 ProteinAdipose tissueDiabetesLipolysisObesityWnt signaling

Identifiers

PMID30948248
PMCPMC6531814
OpenAlexW2921286822

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.